Clinical Trial Update: Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib [Phase 3]

View source ↗

Summary

This Phase 3 trial compares nilotinib with imatinib in Philadelphia chromosome-positive chronic myeloid leukemia patients in early chronic phase who have a subo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)
• Nilotinib (nilotinib)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: UNKNOWN